MISSION STATEMENT

The mission of NEOPATH is to undertake high quality translational and patient-centered research and employ innovative technologies for personalised pathological assessment of head and neck diseases. 

 

We plan to address complex clinical and diagnostic challenges through discovery and analysis of novel biomarkers and foster multidisciplinary and multicenter national and international research collaborations (including low and middle-income countries).

 

Our group aims to actively engage with patients, carers, stakeholders and the public to co-develop studies and improve awareness of head and neck cancers.